Schedule 13D ownership disclosure
TEKMIRA PHARMACEUTICALS CORP
Security class unavailable · CUSIP: 87911B209
Event date: 2015-03-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 29.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-15-051840
- Form type
- SC 13D
- Filer
- Arbutus Biopharma Corp
- CIK
- CIK 1447028
- Filed
- Aug 26, 2015
- Reporting period
- Mar 25, 2015
- Description
- Schedule 13D beneficial ownership